[1] World Health Organization. Global tuberculosis report 2020[R]. Geneva: WHO Press, 2020.
[2] 姚晶,沈鑫,顾凯侃,等. 国内外儿童及学校结核病疫情概况[J]. 结核病与肺部健康杂志,2019,8(2):142-145. DOI:10.3969/j.issn.2095-3755.2019.02.014.
[3] Martinez L, Cords O, Horsburgh CR, et al. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis [J]. Lancet, 2020, 395(10228): 973-984. DOI: 10.1016/S0140-6736(20)30166-5.
[4] 成君,夏愔愔,刘二勇,等. 学校结核病突发疫情处置的思考[J]. 中国防痨杂志,2018,40(2):145-148. DOI:10.3969/j.issn.1000-6621.2018.02.006.
[5] Bao H, Liu K, Wu Z, et al. Tuberculosis outbreaks among students in mainland China: a systematic review and meta-analysis [J]. BMC Infect Dis, 2019, 19(1):972. DOI: 10.1186/s12879-019-4573-3.
[6] Cegolon L, Mastrangelo G, Gentili D, et al. Tuberculosis in schools: an outbreak in northeastern Italy and some key health protection interventions [J]. Croat Med J, 2021, 62(1):90-94. DOI: 10.3325/cmj.2021.62.90.
[7] 刘剑君, 王黎霞.现代结核病学 [M].2版.北京: 人民卫生出版社, 2022: 963-977, 1020-1056.
[8] 中华人民共和国卫生健康委员会.中国结核病预防控制工作技术规范(2020年版)[EB/OL].(2020-04-14).[2022-08-19].https://www. sohu. com/a/387919909_771405.
[9] Teo AKJ, Singh SR, Prem K, et al. Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis [J]. Respir Res, 2021, 22(1): 251. DOI: 10.1186/s12931-021-01841-6.
[10] Bello S, Afolabi RF, Ajayi DT, et al. Empirical evidence of delays in diagnosis and treatment of pulmonary tuberculosis: systematic review and meta-regression analysis [J]. BMC Public Health, 2019, 19(1):820. DOI: 10.1186/s12889-019-7026-4.
[11] Jiang Y, Luo L, Gui M, et al. Duration and determinants of delayed diagnosis with tuberculosis in Shenzhen, China: a cross-sectional study [J]. Risk Manag Healthc Policy, 2022, 15:1473-1481. DOI: 10.2147/RMHP.S367998.
[12] El Halabi J, Palmer N, McDuffie M, et al. Measuring health-care delays among privately insured patients with tuberculosis in the USA: an observational cohort study [J]. Lancet Infect Dis, 2021, 21(8):1175-1183. DOI: 10.1016/S1473-3099(20)30732-5.
[13] Campbell JR, Winters N, Menzies D. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis [J]. BMJ, 2020, 368: m549. DOI: 10.1136/bmj.m549.
[14] 恽朝晖,梁海旭,张莹. 我国大学生结核病防治认知现状及高校健康促进活动[J]. 沈阳医学院学报,2017,19(3):293-297. DOI:10.16753/j.cnki.1008-2344.2017.03.034.
[15] 张文,李春,赵淑娟,等. 北京市大兴区一起民办学校聚集性肺结核疫情的调查处置[J]. 首都公共卫生,2019,13(5):266-269.
[16] Li H, Liu C, Liang M, et al. Tuberculosis outbreak in an educational institution in Henan Province, China [J]. Front Public Health, 2021, 9:737488. DOI: 10.3389/fpubh. 2021.737488.
[17] Norheim G, Seterelv S, Arnesen TM, et al. Tuberculosis outbreak in an educational institution in Norway [J]. J Clin Microbiol, 2017, 55(5):1327-1333. DOI: 10.1128/JCM.01152-16.
[18] Saunders MJ, Tovar MA, Collier D, et al. Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study [J]. Lancet Infect Dis, 2019, 19(5): 519-528. DOI: 10.1016/S1473-3099(18)30753-9.
[19] Chen JO, Qiu YB, Rueda ZV, et al. Role of community-based active case finding in screening tuberculosis in Yunnan province of China [J]. Infect Dis Poverty, 2019, 8(1):92. DOI: 10.1186/s40249-019-0602-0.
[20] Garg T, Gupta V, Sen D, et al. Prediagnostic loss to follow-up in an active case finding tuberculosis programme: a mixed-methods study from rural Bihar, India [J]. BMJ Open, 2020, 10(5):e033706. DOI: 10.1136/bmjopen-2019-033706.
[21] Teo AKJ, Prem K, Evdokimov K, et al. Effect of community active case-finding strategies for detection of tuberculosis in Cambodia: study protocol for a pragmatic cluster randomized controlled trial [J]. Trials, 2020, 21(1):220. DOI: 10.1186/s13063-020-4138-1.
[22] Burke RM, Nliwasa M, Feasey HRA, et al. Community-based active case-finding interventions for tuberculosis: a systematic review [J]. Lancet Public Health, 2021, 6(5):e283-e299. DOI: 10.1016/S2468-2667(21)00033-5.
|